- $14.29m
- $4.16m
Annual cashflow statement for IN8bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -8.56 | -14.7 | -28.5 | -30 | -30.4 |
| Depreciation | |||||
| Non-Cash Items | 0.708 | 2.36 | 3.96 | 5.04 | 5.87 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.628 | -1.84 | -0.17 | -0.204 | -1.41 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -7.13 | -13.5 | -24.1 | -23.3 | -24.1 |
| Capital Expenditures | 0 | -0.309 | -3.71 | -0.6 | -0.187 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | — | — | — | — |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | 0 | -0.309 | -3.71 | -0.6 | -0.187 |
| Financing Cash Flow Items | -1.34 | -2.69 | 0 | — | -0.064 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 24.5 | 33 | 8.99 | 27 | 14.2 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 17.4 | 19.1 | -18.8 | 3.1 | -10.2 |